Eculizumab, SARS-CoV-2 and atypical hemolytic uremic syndrome

Atypical hemolytic uremic syndrome (aHUS) treatment consists of eculizumab. Severe acute respiratory syndrome coronavirus 2 causes severe pneumonia and endothelial injury that leads to a prothrombotic state that may be complicated by macrovascular and microvascular thrombosis. Complement activation...

Descripción completa

Detalles Bibliográficos
Autores principales: Trimarchi, Hernán, Gianserra, Raquel, Lampo, Mauro, Monkowski, Matias, Lodolo, Jimena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Editorial Comments
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543344/
https://www.ncbi.nlm.nih.gov/pubmed/33117528
http://dx.doi.org/10.1093/ckj/sfaa166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543344/
https://www.ncbi.nlm.nih.gov/pubmed/33117528
http://dx.doi.org/10.1093/ckj/sfaa166

Ejemplares similares